Bio Essence Corporation
BIOE
$0.0937
$0.00272.97%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 1,067.12% | -84.96% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1,067.12% | -84.96% | |||
| Cost of Revenue | 5,556.25% | -96.07% | |||
| Gross Profit | 718.45% | -80.73% | |||
| SG&A Expenses | -52.41% | 119.13% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -12.93% | 58.18% | |||
| Operating Income | 129.84% | -5,358.97% | |||
| Income Before Tax | 129.49% | -645.65% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 129.11% | -645.65% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 129.11% | -645.65% | |||
| EBIT | 129.84% | -5,358.97% | |||
| EBITDA | 129.90% | -5,100.00% | |||
| EPS Basic | 129.63% | -671.43% | |||
| Normalized Basic EPS | 129.41% | -580.00% | |||
| EPS Diluted | 129.63% | -671.43% | |||
| Normalized Diluted EPS | 129.41% | -580.00% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||